Menu
GWAS Study

Genetic loci associated with circulating levels of very long-chain saturated fatty acids.

Lemaitre RN, King IB, Kabagambe EK et al.

25378659 PubMed ID
GWAS Study Type
10129 Participants
Scroll to explore
Chapter I

Publication Details

Comprehensive information about this research publication

Authors

LR
Lemaitre RN
KI
King IB
KE
Kabagambe EK
WJ
Wu JH
MB
McKnight B
MA
Manichaikul A
GW
Guan W
SQ
Sun Q
CD
Chasman DI
FM
Foy M
WL
Wang L
ZJ
Zhu J
SD
Siscovick DS
TM
Tsai MY
AD
Arnett DK
PB
Psaty BM
DL
Djousse L
CY
Chen YD
TW
Tang W
WL
Weng LC
WH
Wu H
JM
Jensen MK
CA
Chu AY
JD
Jacobs DR
RS
Rich SS
MD
Mozaffarian D
SL
Steffen L
RE
Rimm EB
HF
Hu FB
RP
Ridker PM
FM
Fornage M
FY
Friedlander Y
Chapter II

Abstract

Summary of the research findings

Very long-chain saturated fatty acids (VLSFAs) are saturated fatty acids with 20 or more carbons. In contrast to the more abundant saturated fatty acids, such as palmitic acid, there is growing evidence that circulating VLSFAs may have beneficial biological properties. Whether genetic factors influence circulating levels of VLSFAs is not known. We investigated the association of common genetic variation with plasma phospholipid/erythrocyte levels of three VLSFAs by performing genome-wide association studies in seven population-based cohorts comprising 10,129 subjects of European ancestry. We observed associations of circulating VLSFA concentrations with common variants in two genes, serine palmitoyl-transferase long-chain base subunit 3 (SPTLC3), a gene involved in the rate-limiting step of de novo sphingolipid synthesis, and ceramide synthase 4 (CERS4). The SPTLC3 variant at rs680379 was associated with higher arachidic acid (20:0 , P = 5.81 × 10(-13)). The CERS4 variant at rs2100944 was associated with higher levels of 20:0 (P = 2.65 × 10(-40)) and in analyses that adjusted for 20:0, with lower levels of behenic acid (P = 4.22 × 10(-26)) and lignoceric acid (P = 3.20 × 10(-21)). These novel associations suggest an inter-relationship of circulating VLSFAs and sphingolipid synthesis.

10,129 European ancestry individuals

Chapter III

Study Statistics

Key metrics and study information

10129
Total Participants
GWAS
Study Type
No
Replicated
European
Ancestry
U.S.
Recruitment Country
Chapter IV

Analysis

Comprehensive review of health and genetic findings

Important Disclaimer: This review has been performed semi-automatically and is provided for informational purposes only. While we strive for accuracy, this analysis may contain errors, omissions, or misinterpretations of the original research. DNA Genics disclaims all liability for any inaccuracies, errors, or consequences arising from the use of this information. Users should independently verify all information and consult original research publications before making any decisions based on this content. This analysis is not intended as a substitute for professional scientific review or medical advice.

Analysis In Progress

Our analysis of this publication is currently being prepared. Please check back soon for comprehensive insights into the health and genetic findings discussed in this research.